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S U M M A R Y
A 35-year-old woman with postoperative recurrent Graves’ disease presented with a 5-day history of a
red swelling on the right cheek associated with 4 days of remittent hyperpyrexia. Investigations revealed
fever, a gangrenous ulcer on the right cheek, submandibular lymphadenopathy, and thyroid gland
enlargement. Her white blood cell count, immunoglobulins, and lymphocyte subsets were unremark-
able. Thyroid function tests showed low thyroid-stimulating hormone, high free thyroxine, and elevated
radioactive iodine uptake. Repeated pus cultures grew Pseudomonas aeruginosa, but blood cultures were
negative. An ill-demarcated erythematous plaque occurred on the right leg on hospital day 3. She was
treated with intravenous antibiotics with topical gentamicin, recombinant bovine basic ﬁbroblast
growth factor, and radioiodine therapy with anti-thyroid drugs. The ulcer healed leaving a depressed
scar at 35 days after discharge. This patient may represent the ﬁrst case of P. aeruginosa ecthyma
gangrenosum and cellulitis in postoperative recurrent Graves’ disease.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Ecthyma gangrenosum (EG) is pathognomonic of underlying
Pseudomonas aeruginosa bacteremia and is characterized by a
necrotic ulceration with black eschar and erythematous rim. It is
most commonly seen in immunocompromised subjects, but
occasionally occurs in healthy people and in patients without
bacteremia.1,2 Although Graves’ disease (GD) is a common organ-
speciﬁc autoimmune disease,3 P. aeruginosa EG has been reported
in only one GD patient with carbimazole-induced agranulocyto-
sis.4 We describe a woman with postoperative recurrent GD who
suffered from P. aeruginosa EG and cellulitis.
2. Case report
A 35-year-old woman presented with a 5-day history of a red
swelling on the right cheek associated with remittent hyperpy-
rexia (39.7 8C) for 4 days. The lesional center had become necrotic
after 3 days of intravenous cephalosporin in a private clinic. Her GD
had been treated with a subtotal thyroidectomy 7 years previously,* Corresponding author. Tel.: +86 759 2369983; fax: +86 759 2231754.
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1201-9712  2014 The Authors. Published by Elsevier Ltd on behalf of International Sobut had relapsed in the last month. On admission, vital signs were:
temperature 38 8C, pulse rate 97 beats/min, respiratory rate 18
breaths/min, and blood pressure 130/80 mmHg. There was a 2-cm
round necrotizing lesion covered with a black eschar and
hemorrhagic vesicles, surrounded by an erythematous halo on
her right cheek (Figure 1a). There were painless submandibular
lymphadenopathy and thyroid gland enlargement, but no
ophthalmopathy. Laboratory ﬁndings revealed a white blood cell
(WBC) count of 6.2  109/l with 58% neutrophils, CD3+ cells 3218/
ml (normal range 770–2041/ml), CD4+ cells 1809/ml (normal range
441–1123/ml), CD8+ cells 1409/ml (normal range 238–874/ml),
albumin 27.6 g/l (normal range 35–54 g/l), C-reactive protein
114 mg/l (normal range <8 mg/l), procalcitonin 0.48 ng/ml
(normal range <0.05 ng/ml), thyroid-stimulating hormone 0.01
mIU/l (normal range 0.34–4 mIU/l), free triiodothyronine
4.49 pmol/l (normal range 2.3–6.3 pmol/l), and free thyroxine
31.7 pmol/l (normal range 7.86–23.5 pmol/l). Blood glucose, liver
and kidney function, immunoglobulins, antinuclear antibodies,
and Weil–Felix tests were normal. Chest radiography and
abdominal sonography results were unremarkable.
Cultures of purulent discharge taken on hospital days 1, 4, and 5
grew P. aeruginosa, but repeated blood cultures were negative. The
isolate was sensitive to piperacillin, piperacillin/tazobactam,
quinolones, and aminoglycosides. The patient was treatedciety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 1. Ecthyma gangrenosum on the right cheek: (a) 2-cm round eschar with erythematous halo on admission; (b) 2.5  2-cm ulcer after debridement on day 8; (c)
2.2  1-cm depressed scar 35 days after discharge.
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compressing of gentamicin. An 8  5-cm tender, edematous, ill-
demarcated erythematous plaque occurred on the outside of the
right leg on day 3. Her WBC count was 15.0  109/l with 67%
neutrophils, and the antibiotic treatment was replaced by
intravenous piperacillin/sulbactam and levoﬂoxacin on day 5.
The patient was also treated with iodine-131 (4.0 mCi), methi-
mazole, and propranolol on day 6. A 2.5  2-cm deep ulcer was
obvious after debridement on day 8 (Figure 1b). The erythematous
plaque on the right leg disappeared on day 11. She was discharged
14 days after admission, and continued to take methimazole and
propranolol, and topical gentamicin. Recombinant bovine basic
ﬁbroblast growth factor (rbFGF) was also given. The ulcer healed
leaving a 2.2  1-cm depressed scar at 35 days after discharge
(Figure 1c).
3. Discussion
EG predominantly affects the axillae, groin, buttocks, and limbs,
and only 6% of cases develop facial involvement. The characteristic
lesion begins as an erythematous nodule, vesicle, or bulla, and
progresses rapidly to necrotic ulceration with a black eschar and
erythematous rim.1,2 Local infarction is due to arterial and venous
thrombosis during bacterial multiplication.1 Although P. aerugi-
nosa is the most common pathogen causing EG, other bacteria
(Staphylococcus aureus, Streptococcus, Aeromonas hydrophila, Ser-
ratia marcescens, Escherichia coli, Klebsiella, Neisseria meningitidis,
Pseudomonas maltophilia, and Stenotrophomonas maltophilia) and
some fungi (Aspergillus, Candida, Fusarium, and Rhizopus) can also
cause EG-like lesions.1,2
EG usually originates from hematogenous dissemination, but
occasionally develops at the inoculation site without bacteremia.2
In our case, the remittent hyperpyrexia and the successive
occurrence of typical EG on the cheek and cellulitis on the leg
suggested P. aeruginosa sepsis. The negative blood culture results
may have been due to the previous treatment with cephalosporin,
but low-grade or transient bacteremia could not be excluded.
Although our patient denied a preexisting facial trauma, an initial
EG followed by fever and another cellulitis implies direct P.
aeruginosa inoculation with secondary septicemia.
To date only one GD patient with anti-thyroid-induced
agranulocytosis has been documented with P. aeruginosa ecthymagangrenosum and facial cellulitis.4 Our patient’s GD was recurrent
after a subtotal thyroidectomy. She had normal immunoglobulin
levels and elevated lymphocyte subsets, and repeated WBC counts
showed no neutropenia. Nonetheless, excess thyroid hormone can
inhibit the activity of natural killer (NK) cells and modulate the
maturation of dendritic cells.3 Therefore, an underlying immune
dysfunction might have left our patient susceptible to P. aeruginosa
infection, although some of her immunological indexes were
unremarkable. Further studies will be necessary to identify the
possible immune deﬁciency caused by immune cell dysfunction
(NK and dendritic cells) in this patient.
The combined use of anti-pseudomonal b-lactam antibiotics
and aminoglycosides is advocated for EG, while wound care with
debridement is essential.1,2 Our patient was at ﬁrst considered for
reconstructive procedures after radioiodine therapy, but the
secondary intention of the ulcer was satisfactory after the topical
application of rbFGF. Since rbFGF can accelerate chronic wound
healing,5 surgical repair may be delayed until the outcome of
conservative management is known.
In conclusion, our patient may represent the ﬁrst case of P.
aeruginosa EG and cellulitis in postoperative recurrent GD.
Clinicians should be alert to P. aeruginosa-induced soft tissue
infections in such patients. The combined use of antibiotics and
wound debridement are the treatment of choice for EG, while
topical rbFGF can enhance ulcer healing.
Ethical approval: Signed informed consent was obtained from
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